A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
Recruiting · NCT04486352 · Registry updated 2026-04-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-01 | NCT04486352 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alliance Foundation Trials, LLC. | 12 |
| Eli Lilly and Company | 370 |
| Foundation Medicine | 9 |
| Genentech, Inc. | 221 |
| Pfizer | 431 |
21 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.